SCHOTT KAISHA expands vial production capacity for COVID-19 vaccine Rs 105 cr investment
The fresh investment will increase vial production by 300 million pieces within 12 months
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Rishad Dadachanji
Sovereign Pharma releases first batch of remdesivir to Cipla
Cipla is likely to launch Cipremi in two to three days
Indian ancillary manufacturers assure uninterrupted supply of materials related to COVID-19 vaccine
In the recent past, many, globally and in India, had raised concerns about a potential shortage of ancillary supplies to…
Maha govt plans to procure 10000 vials of remdesivir from Cipla
It also plans to procure favipiravir from Glenmark